Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety
Abstract Purpose Among the retinal vascular diseases, burden of retinal vein occlusion is most common immediately after diabetic retinopathy. Intravitreal corticosteroids are gaining popularity in managing macular edema (ME) of RVO. Our study compares efficacy and safety of intravitreal triamcinolon...
Main Authors: | S. K. Mishra, A. Gupta, S. Patyal, S. Kumar, K. Raji, A. Singh, V. Sharma |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-03-01
|
Series: | International Journal of Retina and Vitreous |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40942-018-0114-2 |
Similar Items
-
A classic case of ischemic central retinal vein occlusion with macular edema
by: Mani Kruthika Mantha, et al.
Published: (2021-01-01) -
Retinal vein occlusion
by: Rodney Morris
Published: (2016-01-01) -
Cost-effectiveness analysis of ranibizumab for retinal vein occlusion patients in China from the societal perspective
by: Weiyi Ni, et al.
Published: (2021-05-01) -
Twelve-month outcomes in patients with retinal vein occlusion treated with low-frequency intravitreal ranibizumab
by: Sakanishi Y, et al.
Published: (2016-06-01) -
Vasculitic central retinal vein occlusion: The presenting sign of seronegative rheumatoid arthritis
by: Matthew G.J. Trese, et al.
Published: (2016-07-01)